1. Home
  2. WTS vs JAZZ Comparison

WTS vs JAZZ Comparison

Compare WTS & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WTS
  • JAZZ
  • Stock Information
  • Founded
  • WTS 1874
  • JAZZ 2003
  • Country
  • WTS United States
  • JAZZ Ireland
  • Employees
  • WTS N/A
  • JAZZ N/A
  • Industry
  • WTS Metal Fabrications
  • JAZZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • WTS Industrials
  • JAZZ Health Care
  • Exchange
  • WTS Nasdaq
  • JAZZ Nasdaq
  • Market Cap
  • WTS 7.1B
  • JAZZ 8.1B
  • IPO Year
  • WTS 1986
  • JAZZ 2007
  • Fundamental
  • Price
  • WTS $214.83
  • JAZZ $136.01
  • Analyst Decision
  • WTS Hold
  • JAZZ Strong Buy
  • Analyst Count
  • WTS 5
  • JAZZ 14
  • Target Price
  • WTS $220.00
  • JAZZ $177.50
  • AVG Volume (30 Days)
  • WTS 211.5K
  • JAZZ 688.4K
  • Earning Date
  • WTS 02-10-2025
  • JAZZ 02-25-2025
  • Dividend Yield
  • WTS 0.80%
  • JAZZ N/A
  • EPS Growth
  • WTS 11.13
  • JAZZ 458.10
  • EPS
  • WTS 8.69
  • JAZZ 7.04
  • Revenue
  • WTS $2,252,200,000.00
  • JAZZ $3,992,712,000.00
  • Revenue This Year
  • WTS $1.15
  • JAZZ $7.53
  • Revenue Next Year
  • WTS $3.51
  • JAZZ $6.94
  • P/E Ratio
  • WTS $24.81
  • JAZZ $19.42
  • Revenue Growth
  • WTS 9.53
  • JAZZ 5.23
  • 52 Week Low
  • WTS $175.37
  • JAZZ $99.06
  • 52 Week High
  • WTS $232.60
  • JAZZ $138.27
  • Technical
  • Relative Strength Index (RSI)
  • WTS 53.50
  • JAZZ 68.46
  • Support Level
  • WTS $213.72
  • JAZZ $134.56
  • Resistance Level
  • WTS $220.46
  • JAZZ $138.27
  • Average True Range (ATR)
  • WTS 5.82
  • JAZZ 3.56
  • MACD
  • WTS 0.57
  • JAZZ 1.17
  • Stochastic Oscillator
  • WTS 47.35
  • JAZZ 88.20

About WTS Watts Water Technologies Inc.

Watts Water Technologies Inc is a U.S.-based company that provides safety, energy efficiency, and water conservation products. Its product portfolio includes residential and commercial flow control products, which are sold for plumbing and hot water applications; HVAC and gas products, including commercial boilers, water heaters, heating solutions, and heating systems; drainage and water reuse products, including drainage products and engineered rainwater-harvesting solutions; and water quality products, including point-of-use and point-of-entry water filtration, conditioning, and scale prevention systems. The company generates the majority of its revenue from markets in the Americas and in Europe, the Middle East, and Africa.

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Share on Social Networks: